Balter M B, Manheimer D I, Mellinger G D, Uhlenhuth E H
Curr Med Res Opin. 1984;8 Suppl 4:5-20. doi: 10.1185/03007998409109541.
Findings are reported from a 1981 cross-national survey of the use of anti-anxiety/sedative medications by adults in the general population of the United States and 10 Western European countries. Representative national samples in the 11 countries were asked a standard set of questions about their use of these medications during the preceding 12 months. Data were obtained by personal interview in the course of a household visit. The number of persons interviewed ranged from 1486 to 2018. The data provide comparable estimates of past-year prevalence of use-the proportion of the population who took these medications one or more times, and duration of use-and the proportion of the population who took these medications daily for various lengths of time. Rates for past-year prevalence of use varied from 17.6% in Belgium to 7.4% in the Netherlands. The United States at 12.9% was in the middle of the distribution. There was wide variation among countries in the prevalence of long-term and short-term use, but regular daily use for 3 months or less was the predominant pattern in 10 of the 11 countries surveyed. Past-year prevalence rates were much higher for women than for men in every country surveyed. At the national level, the data show that simple past-year prevalence rates and durational parameters of use are relatively independent.
本文报告了1981年一项针对美国及10个西欧国家普通人群中成年人使用抗焦虑/镇静药物情况的跨国调查结果。11个国家具有代表性的全国样本被问及了一组关于他们在前12个月内使用这些药物情况的标准问题。数据是在入户访问过程中通过个人访谈获得的。受访人数从1486人到2018人不等。这些数据提供了过去一年使用 prevalence(此处可能有误,推测为“患病率”)的可比估计值——即服用这些药物一次或多次的人口比例,以及使用 duration(此处可能有误,推测为“持续时间”)——即每天服用这些药物不同时长的人口比例。过去一年的使用患病率从比利时的17.6%到荷兰的7.4%不等。美国为12.9%,处于分布的中间位置。各国在长期和短期使用的患病率方面存在很大差异,但在接受调查的11个国家中有10个国家,持续3个月或更短时间的每日常规使用是主要模式。在每个接受调查的国家中,过去一年女性的患病率都远高于男性。在国家层面,数据表明过去一年的简单患病率和使用持续时间参数相对独立。